You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Claims for Patent: 5,395,760

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,395,760

Title:	DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors
Abstract:	Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
Inventor(s):	Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA)
Assignee:	Immunex Corporation (Seattle, WA)
Application Number:	07/523,635
Patent Claims:	1. An isolated DNA sequence consisting of a DNA sequence encoding only the amino acid sequence selected from the group consisting of amino acids 1-235 of FIG. 2A and amino acids 1-233 of FIG. 3A. 2. An isolated DNA sequence according to claim 1 which encodes a soluble human TNF-R. 3. An isolated DNA sequence consisting of a DNA sequence encoding only the amino acid sequence selected from the group consisting of amino acids 1 through x of FIG. 2A, wherein x is amino acid 163-235 of FIG. 2A. 4. An isolated DNA sequence according to claim 1 which encodes a soluble human TNF-R comprising the sequence of amino acids 1-235 of FIG. 2A. 5. An isolated DNA sequence according to claim 1 which encodes a soluble human TNF-R comprising the sequence of amino acids 1-185 of FIG. 2A. 6. An isolated DNA sequence consisting of a DNA sequence encoding only the amino acid sequence 1-163 of FIG. 2A. 7. An isolated DNA sequence according to claim 1 encoding the TNF-R polypeptide expressed by pCAV/NOT-TNF-R (ATCC 68088). 8. A recombinant expression vector comprising a DNA sequence according to claim 1. 9. A recombinant expression vector comprising a DNA sequence according to claim 2. 10. A recombinant expression vector comprising a DNA sequence according to claim 3. 11. A recombinant expression vector comprising a DNA sequence according to claim 4. 12. A recombinant expression vector comprising a DNA sequence according to claim 5. 13. A recombinant expression vector comprising a DNA sequence according to claim 6. 14. A recombinant expression vector comprising a DNA sequence according to claim 7. 15. A host cell transformed or transfected with the vector according to claim 9. 16. A host cell transformed or transfected with the vector according to claim 10. 17. A host cell transformed or transfected with the vector according to claim 11. 18. A host cell transformed or transfected with the vector according to claim 12. 19. A host cell transformed or transfected with the vector according to claim 13. 20. A host cell transformed or transfected with the vector according to claim 14.

Details for Patent 5,395,760

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Immunex Corporation	ENBREL	etanercept	For Injection	103795	November 02, 1998	5,395,760	2012-03-07
Immunex Corporation	ENBREL	etanercept	For Injection	103795	May 27, 1999	5,395,760	2012-03-07
Immunex Corporation	ENBREL	etanercept	Injection	103795	September 27, 2004	5,395,760	2012-03-07
Immunex Corporation	ENBREL	etanercept	Injection	103795	February 01, 2007	5,395,760	2012-03-07
Immunex Corporation	ENBREL MINI	etanercept	Injection	103795	September 14, 2017	5,395,760	2012-03-07
Immunex Corporation	ENBREL	etanercept	Injection	103795		5,395,760	2012-03-07
Immunex Corporation	ENBREL	etanercept	Injection	103795	March 05, 2020	5,395,760	2012-03-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 5,395,760

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
South Africa	907072	⤷ Subscribe
World Intellectual Property Organization (WIPO)	9406476	⤷ Subscribe
World Intellectual Property Organization (WIPO)	9319777	⤷ Subscribe
World Intellectual Property Organization (WIPO)	9103553	⤷ Subscribe
United States of America	RE36755	⤷ Subscribe
United States of America	7459528	⤷ Subscribe
United States of America	7057022	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.